InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Gollob Jared, Directeur Médical. Officer active across 2 companies, notably Kymera Therapeutics, Inc.. Aggregated, 4 filings have been logged. The latest transaction was filed on 4 May 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations4 total
€12,58910,208 shares@ €1.23320.0002% mcap35.7% of flow
Common Stock
SEC:0000899243-22-016538:0·
012,600 shares0
Common Stock
SEC:0000899243-22-009076:0·
€22,67120,000 shares@ €1.13350.0004% mcap100.0% of flow
Common Stock
SEC:0000899243-21-042437·
€22,67120,000 shares@ €1.13350.0004% mcap64.3% of flow
Common Stock
SEC:0000899243-21-042437:0·
4 of 4 declarations
About Gollob Jared
Jared Gollob is the Chief Medical Officer of Kymera Therapeutics, Inc. In this role, he is responsible for the medical direction of the company, overseeing research and development activities related to therapeutic products. His expertise in medicine and biotechnology is essential for guiding clinical initiatives and ensuring that the treatments developed meet the highest standards of safety and efficacy.
